MENU
+Compare
DHTRF
Stock ticker: OTC
AS OF
Aug 11 closing price
Price
$10.31
Change
-$0.07 (-0.67%)
Capitalization
574.99M

DHTRF DRI HEALTHCARE TR Forecast, Technical & Fundamental Analysis

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies... Show more

DHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DHTRF with price predictions
Sep 05, 2025

Aroon Indicator for DHTRF shows an upward move is likely

DHTRF's Aroon Indicator triggered a bullish signal on August 13, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 95 similar instances where the Aroon Indicator showed a similar pattern. In of the 95 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on August 25, 2025. You may want to consider a long position or call options on DHTRF as a result. In of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for DHTRF turned negative on August 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.136) is normal, around the industry mean (16.681). P/E Ratio (147.286) is within average values for comparable stocks, (74.219). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). Dividend Yield (0.036) settles around the average of (0.031) among similar stocks. P/S Ratio (4.141) is also within normal values, averaging (42.934).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DHTRF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DHTRF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
DHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

DHTRF paid dividends on July 18, 2025

DRI HEALTHCARE TR DHTRF Stock Dividends
А dividend of $0.10 per share was paid with a record date of July 18, 2025, and an ex-dividend date of June 30, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
100 King Street West
Phone
+1 416 863-1865
Employees
33
Web
https://www.dricapital.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TDFCX8.42N/A
N/A
Transamerica Sustainable Equity Inc C
FTMSX26.92N/A
N/A
FullerThaler Behvrl Mcr-Cp Eq Instl
AVUAX16.78N/A
N/A
American Century Mid Cap Value I
AWSYX17.39N/A
N/A
Invesco Global Core Equity Y
RLITX16.02N/A
N/A
Lazard International Strategic Eq R6

Groups containing DHTRF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHTRF
1D Price
Change %
DHTRF100%
N/A
Pharmaceuticals: Generic
industry (222 stocks)
-2%
Poorly correlated
+2.50%
Pharmaceuticals
industry (386 stocks)
-4%
Poorly correlated
+1.70%